PIBIDS: Tay's syndrome and xeroderma pigmentosum

Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011].

Journal of Crohn's & colitis·2017

Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.

Gut·2016

Usability Flaws in Medication Alerting Systems: Impact on Usage and Work System.

Yearbook of medical informatics·2015

[Ki67 in young patients with breast cancer].

Gynecologie, obstetrique & fertilite·2013

Two Caucasian families with the hepatocyte nuclear factor-1alpha mutation Tyr218Cys.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2007

Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2006

Molecular Alterations in Patients of Color with Advanced Cutaneous and Unknown Primary Melanomas.

Journal of the American Academy of Dermatology·2026

Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.

Journal of the American Academy of Dermatology·2026

Clinical Spectrum and Emerging Therapeutic Approaches in Trigeminal Trophic Syndrome: Diagnostic Challenges and Pitfalls.

Journal of the American Academy of Dermatology·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

PIBIDS: Tay's syndrome and xeroderma pigmentosum

Related Concept Videos

Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011].

Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.

Usability Flaws in Medication Alerting Systems: Impact on Usage and Work System.

[Ki67 in young patients with breast cancer].

Two Caucasian families with the hepatocyte nuclear factor-1alpha mutation Tyr218Cys.

Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population.

Molecular Alterations in Patients of Color with Advanced Cutaneous and Unknown Primary Melanomas.

Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.

Clinical Spectrum and Emerging Therapeutic Approaches in Trigeminal Trophic Syndrome: Diagnostic Challenges and Pitfalls.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

PIBIDS: Tay's syndrome and xeroderma pigmentosum

Related Concept Videos

Related Articles